Replimune Group, Inc.
For the period ended Mar 31, 2026. Filed Jun 29, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Jun 29, 2026
REPL$21.62+8.0%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. 10-K summary
None.
Index to Consolidated Financial Statements
For the Years Ended March 31, 2026 and 2025
| Page | |
| Report of independent registered public accounting firm (PCAOB ID 238) | F-2 |
|---|---|
| Consolidated balance sheets | F-4 |
| Consolidated statements of operations | F-5 |
| Consolidated statements of comprehensive loss | F-6 |
| Consolidated statements of stockholders’ equity | F-7 |
| Consolidated statements of cash flows | F-8 |
| Notes to consolidated financial statements | F-9 |
F - 1
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.